Remdesivir Completed Phase 3 Trials for COVID / Coronavirus Disease 2019 (COVID‑19) / Severe Acute Respiratory Syndrome (SARS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04546581Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC)